A+ = 95.0+
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
C+ = 75.0-77.9
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
Based on KLAS' Decision Insights data, the market energy indicator reflects the frequency with which a vendor is seriously considered and replaced compared to what would be expected based on the number of vendors in the market and the number of purchase decisions recorded.
Market average: 82.2
Software average: 80.6
Overall performance score (100-point scale) |
Trend (2024-2025) |
# of unique orgs |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
Market energy
|
||
|
Bluesight
ControlCheck 
|
86.1 |
+2%
|
32
|
B
|
A-
|
B+
|
B
|
B
|
A-
|
||
| |
|
|
|
|
|||||||
|
Bluesight
(formerly Protenus) Protenus Diversion Analytics
|
84.3 |
-1%
|
21
|
B+
|
B
|
B
|
B-
|
B+
|
B+
|
||
| |
|
|
|
|
|||||||
|
BD
HealthSight Diversion Management
|
74.6 |
-6%
|
30
|
C+
|
C
|
C
|
C
|
B-
|
C+
|
||
0.0 |
100.0 |
||||||||||
86.1
32
culture
B
loyalty
A-
operations
B+
product
B
relationship
B
value
A-
culture
B+
loyalty
B
operations
B
product
B-
relationship
B+
value
B+
culture
C+
loyalty
C
operations
C
product
C
relationship
B-
value
C+
Additional Performance Insights
Additional Performance Insights
Ranked solutions for which at least 95% of respondents answered yes.
Avoids charging for every little thing?
Bluesight
ControlCheck
ControlCheck
n=28 97%
Keeps all promises?
Bluesight (formerly Protenus)
Protenus Diversion Analytics
Protenus Diversion Analytics
n=20 95%
Avoids charging for every little thing?
Bluesight
ControlCheck
ControlCheck
n=28 97%
Keeps all promises?
Bluesight (formerly Protenus)
Protenus Diversion Analytics
Protenus Diversion Analytics
n=20 95%
Solutions Not Ranked
Ordered alphabetically
L
|
Overall performance score (100-point scale) |
# of unique orgs |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
Market energy |
|
|
HelioMetrics
Drug Diversion Analytics L |
84.9 |
8
|
B-
|
B-
|
B
|
B+
|
A
|
A
|
|
| |
|
|
|
|
|||||
|
Imprivata
Drug Diversion Intelligence L |
82 |
13
|
B+
|
B
|
B-
|
C+
|
B
|
B
|
|
| |
|
|
|
|
|||||
|
Wolters Kluwer
Sentri7 Drug Diversion L |
77.9 |
8
|
C
|
C+
|
C-
|
B
|
B-
|
A-
|
L
&nbps;
HelioMetrics
Drug Diversion Analytics L
Drug Diversion Analytics L
84.9
8
8
culture
B-
loyalty
B-
operations
B
product
B+
relationship
A
value
A
Imprivata
Drug Diversion Intelligence L
Drug Diversion Intelligence L
82
13
13
culture
B+
loyalty
B
operations
B-
product
C+
relationship
B
value
B
Wolters Kluwer
Sentri7 Drug Diversion L
Sentri7 Drug Diversion L
77.9
8
8
culture
C
loyalty
C+
operations
C-
product
B
relationship
B-
value
A-
